ANCA and Anti GBM antibody disease Flashcards

1
Q

what are the pulmonary renal syndrome and what are the 2 subtypes

A

development of diffuse alveolar hemorrhage and glomerulonephritis

  • ANCA-associated vasculitis
  • Anti-GBM disease (goodpasture disease)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is a cardiorenal syndrome?

A

Development of renal failure in setting of acute or chronic heart failure
-there are 5 types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is a hepatorenal syndrome?

A

Development of renal failure in the setting of cirrhosis (portal hypertension)
-type 1 and 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the three ANCA-Associated small vessel vasculitis

A

Microscopic polyangitis
Granulomatosis with polyangiitis
Eosinophillic granulamatosis with polyangiitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are immune complex small vessel vasculitis

A

Cryoglobulinemic vasculitis
IgA vasculitis (henoch-schonlen)
Hypocomplementemic urticarial vasculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what does ANCA stand for and what are the two types

A

Antineutrophil cytoplasmic antibodies

  • PR3 causes C-ANCA
  • MPO causes P-ANCA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

characteristics of Granuomatosis with polyangitis?

A

necrotizing vasculitis with necrotizing granulomas affecting respiratory tract (upper or lower) with no asthma symptoms or eosiophilla

associated with PR3-ANCA (c-ANCA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

characteristics of Microscopic polyangiitis?

A

Nectorizing vasculitis without granulomas r asthma symptoms or eosinophilia

associated with MPO-antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Characteristics of Eosinophilic granulomatosis with polyangiitis

A

necrotizing vasculitis with necrotizing granulomas affecting respiratory tract (upper and lower) with asthma symptoms and eosinophila

typically associated with MPO antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PR3-ANCA vs MPO-ANCA which one has higher relapse rates, which has higher mortality rates?

A

PR3-ANCA disease has a higher relapse rate

MPO-ANCA disease has a higher mortality rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Epidemiology of ANCA associated Vasculitis

A

AAV more common in men and Caucasians and asians than African americans

GPA more common in North America and australia
MPA more common in southern Europe and asia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Major clinical manifestations of ANCA associated vasculitis

A

Constitutional symptoms:
-fever, malaise, anorexia, weight loss, myalgias, and migratory arthralgias

ENT manifestations
Pulmonary cough, dyspnea and hemoptysis

Skin: palpable purpura

Renal: hematuria, proteinuria, and renal failure

Neurologic:
-Mononeuritis multiplex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what vasculitis is ENT symptoms more common

A

GPA: Granuomatosis with polyangitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is palpable purpura suggestive of

what is non-palapable purpura suggestive of

A

Palpable purpura: raised non blanching erythematous lesion suggestive of vasculitis

Non-palpable purpura is a non blanching erythematous lesion usually from simple hemorrhage in skin suggestive of thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what do you need for a definitive diagnosis of ANCA associated vasculitis

A

Definitive diagnosis requires a biopsy

ANCA testing

Anti GBM antibody testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the Treatment for ANCA associated vasculitis

A

Induction therapy:
High dose glucocorticoids + rituximab
High dose glucocorticoids + cyclophosphamide

Maintenance therapy:

  • 1st line azathioprine or mycophenolate or rituximab
  • 2nd line Methotrexate
17
Q

what must you test for to determine dosing of azathioprine in ANCA associated vasculitis

A

Thiopurine methyltransferase testing because this effects the dosage of azathioprine initially

18
Q

what are the main complications of ANCA associated Vasculitis

A

Lungs:

  • Hemoptysis from diffuse alveolar hemorrhage
  • respiratory failure

Kidneys:

  • Pauci-immune glomerulonephritis (can be rapidly progressive GN, RPGN)
  • Renal failure
19
Q

what is the epidemiology of anti-GBM disease and what is special about its distribution

A

Anti-GBM disease is a small vessel vasculitis in which antibodies are directed against the glomerular basement membrane (GBM) and alveolar basement membrane (ABM)

more common in caucasians

Bimodal distribution

  • 2nd decade of life (more likely to be male and both renal and pulmonary involvement)
  • 6th decade of life (more likely female and usually only renal involvement)
20
Q

what can Anti-GBM disease be associate with as well?

A

ANCA associated vasculitis (usually MPO)

21
Q

what is anti GBM antibodies directed at?

A

Type 4 collagen in Mature GBM specifically A3 chains

22
Q

what mutation is found in alport syndrome

A

Type 4 collage specifically mutation in the a5 chain

23
Q

what is the pathogenesis of Anti-GBM disease

A

Not fully understood

  • genetic predisposition
  • environmental trigger or infection may expose A3 chain to the immune system
  • antibodies are directed primarily at the NC1 portion of the a3 chain
24
Q

what are the classic clinical presentation for the anti-GBM disease

A

Most patients present with systemic signs and symptoms

  • fever, malaise, weight loss, and arthralgias but just for a few weeks
  • symptoms longer then suggest patient has both anti-GBM disease and ANCA positivity

Rapidly progressive GN (RPGN)
Nephritic syndrome

Diffuse alveolar hemorrhage
-dyspnea, cough, hemoptysis, pulmonary infiltrates on CXR

25
Q

what is the diagnosis of anti-GBM disease?

A

should be suspected in any patient with RPGN and nephritic syndrome, especially if there is concurrent pulmonary hemorrhage

Testing:

  • anti-GBM antibody
  • ANCA testing
  • Renal biopsy
  • crescentic glomerulonephritis with liner IgG staining along the GBM
  • chest x-ray, CT chest , and/or bronchoscopy with BAL
26
Q

what is the pathologic diagnosis of Anti-GBM?

A

demonstration by immunofluorescence of diffuse linear IgG staining along the GBMs in the setting of crescentic glomerulonephritis

27
Q

Treatment of Anti-GBM disease

A

Plasmapheresis + high dose glucocorticoids + cyclophosphamide

rituximab used in refactory disease

28
Q

blood layers in plasmapharesis

A
  • Plasma
  • Platelets
  • Buffy Coat
  • Packed RBCs